Percheron Therapeutics (AU:PER) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Percheron Therapeutics has reported a significant change in its substantial shareholding, as Platinum Investment Management disclosed an increase in its stake to 10 million ordinary shares, representing 9.5796% of the company. This development could signal increased confidence in Percheron’s growth prospects, attracting the attention of investors keen on biotechnology stocks.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
